Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

May 8, 2021

Preventing Abuse and Multiple Sclerosis

  • Mental Health
    /
  • Multiple Sclerosis
    /
  Click HERE to Subscribe for the MS Beacon eNewsletter Multiple sclerosis (MS) can affect any part of the central nervous…
Mental Health

May 8, 2021

Optic Neuritis: How Does MS Affect Vision?

  • Multiple Sclerosis (MS) Symptoms
    /
  Click HERE to Subscribe for the MS Beacon eNewsletter Optic neuritis (ON) is an inflammatory and demyelinating eye condition that causes eye…
Multiple Sclerosis (MS) Symptoms

May 8, 2021

MS and Heat: What You Need To Know

  • Multiple Sclerosis (MS) Symptoms
    /
  Click HERE to Subscribe for the MS Beacon eNewsletter Many people with multiple sclerosis (MS) are sensitive to heat and changes…
Multiple Sclerosis (MS) Symptoms

May 8, 2021

Phase 4 Trial Will Test if Ocrevus Can Prevent MS Onset in RIS Patients

  • MS Research Study and Reports
    /
  • Ocrevus
    /
  • SPMS-PPMS News
    /
Yale University is launching CELLO, a multicenter study to investigate the efficacy of Ocrevus (ocrelizumab) in treating people with lesions suggestive of multiple sclerosis (MS),…
MS Research Study and Reports

May 3, 2021

Boster Video: Cognitive Impairment: Multiple Sclerosis Symptoms Confuse Friends and Family

  • Boster's MS Corner
    /
  • MS Educational Programs
    /
  Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
Boster's MS Corner

May 3, 2021

COVID-19 in ocrelizumab-treated people with multiple sclerosis

  • MS Research Study and Reports
    /
  • Ocrevus
    /
  Abstract Background: There are limited data on the impact of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory…
MS Research Study and Reports

May 3, 2021

Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years

  • Lemtrada
    /
  • MS Relapse-Exacerbation
    /
  Abstract Background: Alemtuzumab significantly improved clinical and MRI outcomes vs. subcutaneous interferon beta-1a (SC IFNB-1a) in the CARE-MS trials (NCT00530348, NCT00548405),…
Lemtrada

May 3, 2021

Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis

  • MS Research Study and Reports
    /
  • Tysabri
    /
 Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian…
MS Research Study and Reports

April 29, 2021

Steroids for MS – Treatment Basics, Side Effects and More

  • Additional MS resource sites
    /
  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
 People with relapsing remitting MS often experience relapses, during which they may experience new MS symptoms or the worsening of…
Additional MS resource sites

April 29, 2021

The Indispensable Role of Caregivers

  • Caregiver related
    /
  • Multiple Sclerosis
    /
It’s vitally important to support caregivers and pay attention to their needs, as they are the backbone of many families…
Caregiver related

Categories

Latest Blog Posts